 FSD Pharma Inc NASDAQ:HUGE CSE:HUGE said it has submitted to the US Food and Drug Administration an Investigational New Animal Drug Application IND for the use of FSD201 to treat gastrointestinal enteropathy in dogs. The application has been accepted for review, the company added in a statement. 